Charles River Laboratories Other Non-Cash Items 2010-2025 | CRL

Charles River Laboratories annual/quarterly other non-cash items history and growth rate from 2010 to 2025. Other non-cash items can be defined as miscellaneous non-cash adjustments to Net income.
  • Charles River Laboratories other non-cash items for the quarter ending March 31, 2025 were $0.020B, a 9.93% increase year-over-year.
  • Charles River Laboratories other non-cash items for the twelve months ending March 31, 2025 were $0.228B, a 89.37% increase year-over-year.
  • Charles River Laboratories annual other non-cash items for 2024 were $0.13B, a 1494.55% decline from 2023.
  • Charles River Laboratories annual other non-cash items for 2023 were $-0.009B, a 76.99% decline from 2022.
  • Charles River Laboratories annual other non-cash items for 2022 were $-0.04B, a 179.35% decline from 2021.
Charles River Laboratories Annual Other Non-Cash Items
(Millions of US $)
2024 $130
2023 $-9
2022 $-40
2021 $51
2020 $-35
2019 $20
2018 $20
2017 $56
2016 $42
2015 $30
2014 $31
2013 $24
2012 $32
2011 $25
2010 $83
2009 $42
Sector Industry Market Cap Revenue
Medical Medical Services $7.034B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $138.181B 25.92
Elevance Health (ELV) United States $85.871B 11.08
CVS Health (CVS) United States $80.417B 10.00
Cencora (COR) United States $56.019B 19.49
Natera (NTRA) United States $22.833B 0.00
DiDi Global (DIDIY) China $22.168B 33.64
BioMerieux (BMXMF) France $15.890B 0.00
Solventum (SOLV) United States $13.000B 13.76
EUROFINS SCIENT (ERFSF) Luxembourg $12.955B 0.00
CochLear (CHEOY) Australia $11.511B 0.00
ICON (ICLR) Ireland $11.274B 10.48
Revvity (RVTY) United States $10.891B 18.74
Doximity (DOCS) United States $10.250B 47.45
Viatris (VTRS) United States $10.082B 3.46
HealthEquity (HQY) United States $9.777B 42.83
Avantor (AVTR) United States $9.070B 13.18
Medpace Holdings (MEDP) United States $8.989B 23.87
Sonic Healthcare (SKHHY) Australia $8.365B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
BrightSpring Health Services (BTSG) United States $4.109B 38.03
Bausch + Lomb (BLCO) Canada $4.068B 23.98
Sotera Health (SHC) United States $3.508B 19.93
Alignment Healthcare (ALHC) United States $3.031B 0.00
Surgery Partners (SGRY) United States $2.955B 38.43
Concentras Parent (CON) United States $2.766B 15.98
Organon (OGN) United States $2.477B 2.63
Ardent Health Partners (ARDT) United States $2.084B 8.88
GeneDx Holdings (WGS) United States $2.066B 79.55
Premier (PINC) United States $1.908B 14.48
Progyny (PGNY) United States $1.826B 40.19
PACS (PACS) United States $1.550B 0.00
GoodRx Holdings (GDRX) United States $1.432B 28.64
Teladoc Health (TDOC) United States $1.249B 0.00
Pediatrix Medical (MD) United States $1.194B 9.09
Establishment Labs Holdings (ESTA) $1.075B 0.00
CareDx (CDNA) United States $1.075B 16.78
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.907B 0.00
AMN Healthcare Services Inc (AMN) United States $0.768B 7.19
QDM (QDMI) Hong Kong, SAR China $0.755B 0.00
Nutex Health (NUTX) United States $0.753B 11.41
Embecta (EMBC) United States $0.608B 4.09
LifeMD (LFMD) United States $0.559B 0.00
Enhabit (EHAB) United States $0.538B 44.25
InnovAge Holding (INNV) United States $0.535B 0.00
SBC Medicals (SBC) United States $0.502B 0.00
Auna S.A (AUNA) Luxembourg $0.486B 10.95
Sonida Senior Living (SNDA) United States $0.460B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.423B 0.00
Oncology Institute (TOI) United States $0.286B 0.00
Performant Healthcare (PHLT) United States $0.240B 0.00
Beauty Health (SKIN) United States $0.210B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.147B 24.00
KindlyMD (NAKA) United States $0.103B 0.00
So-Young (SY) China $0.097B 0.00
Basel Medical Group (BMGL) Singapore $0.090B 0.00
OncoCyte (OCX) United States $0.084B 0.00
Ascend Wellness Holdings (AAWH) United States $0.073B 0.00
Sera Prognostics (SERA) United States $0.064B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Pheton Holdings (PTHL) China $0.046B 0.00
Biodesix (BDSX) United States $0.043B 0.00
ModivCare (MODV) United States $0.033B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.011B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00